Home/Filings/4/0001209191-23-041094
4//SEC Filing

Domzalski David 4

Accession 0001209191-23-041094

CIK 0001566044other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:30 PM ET

Size

5.1 KB

Accession

0001209191-23-041094

Insider Transaction Report

Form 4
Period: 2023-06-30
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
  • Tax Payment

    Common Stock

    2023-06-30$4.10/sh981$4,02252,433 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001727794

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:30 PM ET
Size
5.1 KB